Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies.
暂无分享,去创建一个
K. van Besien | P. Christos | U. Gergis | T. Shore | S. Mayer | A. Phillips | H. Choe | J. Hsu
[1] H. Rennert,et al. Haplo-cord transplant: HLA-matching determines graft dominance , 2017, Leukemia & lymphoma.
[2] R. Childs,et al. Haploidentical cord transplantation-The best of both worlds. , 2016, Seminars in hematology.
[3] R. Larson,et al. Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[4] R. Larson,et al. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival , 2016, Haematologica.
[5] I. Buño,et al. Haplo-cord transplantation using CD34+ cells from a third-party donor to speed engraftment in high-risk patients with hematologic disorders. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[6] R. Pearse,et al. A strategy to reduce donor-specific HLA Abs before allogeneic transplantation , 2014, Bone Marrow Transplantation.
[7] H. Tamaki,et al. Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT , 2012, Bone Marrow Transplantation.
[8] P. Terasaki,et al. Durability of Antibody Removal Following Proteasome Inhibitor-Based Therapy , 2012, Transplantation.
[9] J. Ritz,et al. Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation. , 2011, Blood.
[10] R. Larson,et al. Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions. , 2011, Blood.
[11] P. Thall,et al. Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. , 2011, Blood.
[12] H. Azuma,et al. The impact of anti-HLA antibodies on unrelated cord blood transplantations. , 2010, Blood.
[13] P. Terasaki,et al. Abrogation of Anti-HLA Antibodies via Proteasome Inhibition , 2009, Transplantation.
[14] M. Stegall,et al. Proteasome Inhibition Causes Apoptosis of Normal Human Plasma Cells Preventing Alloantibody Production , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[15] J. Klein,et al. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. , 2007, Blood.
[16] J. Hows,et al. Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia , 2004, Transfusion.
[17] R. Hansen,et al. Intravenous Immunoglobulin Mediates an Increase in Anti-Platelet Antibody Clearance via the FcRn Receptor , 2002, Thrombosis and Haemostasis.
[18] W. Stock,et al. Stem cell transplantation eliminates alloantibody in a highly sensitized patient. , 2001, Transplantation.
[19] A. Ballestrero,et al. Proteasome inhibitors: antitumor effects and beyond , 2007, Leukemia.
[20] Schroeder Jo,et al. Antibody rebound after plasmapheresis: experimental evidence and clinical consequences. , 1990 .
[21] H. Euler,et al. Antibody rebound after plasmapheresis: experimental evidence and clinical consequences. , 1990, Progress in clinical and biological research.